Invesaro

Companies AEMD 8-K

SEC filing · 8-K

Aethlon Medical Inc: Executive or director change

Aethlon Medical stockholders approved all proposals at the annual meeting, including an expansion of authorized shares and an equity plan amendment.

Filed October 1, 2026

Positive for the company

What happened

  • Stockholders approved increasing authorized common stock from 20,000,000 to 200,000,000 shares and authorized 20,000,000 shares of preferred stock.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Back to Aethlon Medical Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.